Statins' Benefits Begin to Sprout

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2001 Aug 8

PMID 11489928

Citations 4

Authors

D C Altieri

Affiliations

Soon will be listed here.

Citing Articles

Therapeutic Arteriogenesis/Angiogenesis for Peripheral Arterial Disease by Nanoparticle-Mediated Delivery of Pitavastatin into Vascular Endothelial Cells.

Matsumoto T, Yamashita S, Yoshino S, Kurose S, Morisaki K, Nakano K Ann Vasc Dis. 2020; 13(1):4-12.

PMID: 32273916 PMC: 7140170. DOI: 10.3400/avd.ra.19-00130.

Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw.

Adachi N, Ayukawa Y, Yasunami N, Furuhashi A, Imai M, Sanda K Sci Rep. 2020; 10(1):5620.

PMID: 32221325 PMC: 7101417. DOI: 10.1038/s41598-020-61724-6.

Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells.

Osman L, Amrani M, Ilsley C, Yacoub M, Smolenski R Mol Cell Biochem. 2007; 308(1-2):209-17.

PMID: 18158588 DOI: 10.1007/s11010-007-9630-3.

Does simvastatin stimulate bone formation in vivo?.

von Stechow D, Fish S, Yahalom D, Bab I, Chorev M, Muller R BMC Musculoskelet Disord. 2003; 4:8.

PMID: 12718758 PMC: 156891. DOI: 10.1186/1471-2474-4-8.

References

Libby P . Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol. 2000; 86(8B):3J-8J; discussion 8J-9J. DOI: 10.1016/s0002-9149(00)01339-4. View

Sessa W . Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?. Trends Mol Med. 2001; 7(5):189-91. DOI: 10.1016/s1471-4914(01)01985-2. View

Waters D . What do the statin trials tell us?. Am J Manag Care. 2001; 7(5 Suppl):S138-43. View

Dimmeler S, Aicher A, Vasa M, Adler K, Tiemann M, Rutten H . HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001; 108(3):391-7. PMC: 209365. DOI: 10.1172/JCI13152. View

Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A . HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest. 2001; 108(3):399-405. PMC: 209363. DOI: 10.1172/JCI13131. View